AHRP Press Briefing: Antidepressants and Suicide-Related Risks for Children


Scientists’ Presentations at AHRP Press Briefing in Conjunction with FDA Hearings:

  • Peter Mansfield, MD, University of Adelaide (Australia), Director of Healthy Skepticism discussed the illusion of potency in light of the meta-analyses in the British Medical Journal (which he co-authored) and the Lancet.
    Dr. Mansfield’s power point presentation
  • Peter Breggin, MD, a psychiatrist with a sub-specialty in clinical psychopharmacology, who was among the first to recognize adverse antidepressant drug reactions
    Dr. Breggin’s presentation
  • Lawrence Diller, MD, a pediatrician and family therapist who has evaluated and treated more than 2,500 children
    Dr. Diller’s presentation
  • Stefan Kruszewski, MD, a clinical and academic psychiatrist, and Associate Medical Director of Physicians’ Health Programs, Pennsylvania Medical Society
    Dr. Kruszewski’s presentation
  • David Healy, MD, Director of the North Wales Department of Psychological Medicine and Visiting Professor, University of Toronto,

FDA’s Waiting Game Exposes Children to Preventable Risks – 9/04 AHRP Comments to FDA

FDA’s Waiting Game Exposes Children to Preventable Risks Comments by Vera Hassner Sharav President The Alliance for Human Research Protection Submitted to FDA Advisory Committee Psychopharmacological Drugs Advisory Committee and Pediatric Subcommittee Drugs Advisory Committee September 13-14, 2004 Meeting RE: Suicidality Associated with Antidepressant Drug Treatment The Alliance for Human…

AHRP Press Briefing Re: Antidepressant Drug Risks

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P, New York, NY 10023 ***PRESS RELEASE*** September 11, 2004 Contact: Vera Hassner Sharav, President, AHRP Tel. No: 212-595-8974 Cell: 917-375-5083 ***AHRP PRESS BRIEFING*** Re: Antidepressants and suicide-related risks for children When: September 14, 2004, 12:00 P.M. Where: Holiday…

Conflict of Interest

Conflict of Interest: Profits vs Safety Congressional Investigations US Senators Pharmaceutical industry holdings, 2004: http://www.consumerwatchdog.org/resources/SenPharma.pdf Oct 12: How Did the Vioxx Debacle Happen? USA Today / Lancet Oct 4: Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical…

AHRP Press Briefing: Scientists Will Analyze SSRI Data – Families Will Tell Their Tragedies

AHRP Press Briefing Scientists Will Analyze SSRI Data – Families Will Tell Their Tragedies THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P New York, NY 10023 January 27, 2004 Contact: Vera Hassner Sharav President, AHRP Tel. No: 212-595-8974 E-mail: Contact: Lisa Van Syckel Family Liaison…

AHRP Press Briefing: Scientists Will Analyze SSRI Data, Families Will Tell Their Tragedies

Excerpt: The British drug authority has banned the use of most SSRI antidepressant drugs for the treatment of depression in children under 18, citing a two-to-threefold increased risk of suicidal behavior and lack of evidence of a benefit for depressed children. Two SSRIs – Paxil and Effexor – are no longer recommended by their manufacturer for use in children. Prozac is no longer recommended by Eli Lilly for children in the U.K.

In contrast to the British medicines authority review of the evidence, the FDA has refused to allow independent scientists to present documented evidence related to these drugs’ hazards and their failure to demonstrate a benefit for depressed children.

AHRP Correspondence with Government Agencies

AHRP Correspondence with Government Agencies related link: FDA response to AHRP procedural questions (FDA sham conflicts of interest policy) FDA re: supression of SSRI evidence ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave, Suite 28P New York, NY 10023 https://ahrp.org Tel: 212-595-8974 e-mail: October 29, 2003 To: Thomas…

Debate Resumes on the Safety of Depression’s Wonder Drugs – NYT

Debate Resumes on the Safety of Depression’s Wonder Drugs – NYT Thu, 7 Aug 2003 After a decade of lies, deception, and cover-up of evidence linking antidepression drugs – such as, Prozac, Paxil, Zoloft – to acts of suicide in previously non-suicidal people – children and adults, some of who…

Toxicologist Blames Prozac for Wife’s Suicide – UK

Toxicologist Blames Prozac for Wife’s Suicide – UK Fri, 27 Jun 2003 News reports from the UK are awash with cases of drug-induced violent suicidal behavior by patients taking Prozac, Paxil and the other antidepressant drugs in their class–i.e., selective serotonin reuptake inhibitors. A coroner’s inquest of the suicide by…

18 Deaths Linked to drug – Serzone Removed from European market, not US

18 Deaths Linked to drug – Serzone Removed from European market, not US Fri, 17 Jan 2003 Bloomberg News reported that the antidepressant, Serzone had been linked to 25 cases of liver damage and 18 deaths. On Jan 8, 2003 European authorities removed the drug from the European market. On…

Infomail Archive Pre 2003

Infomail Archive – Pre 2003 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav December 28, 2002: Will 2 to 5 year old Amer. kids be exposed to Smallpox Vaccine? Israeli Intelligence says “No immediate threat” December 24, 2002: Moral turpitude: Herpes experiment surpasses Tuskegee December 20,…

Investigative series finds kids drugged without cause – Journal News

November 08, 2002 Investigative series finds kids drugged without cause – Journal News The Journal News, a regional NYS newspaper conducted a three month investigation of residential treatment centers (RTC) for troubled children in NYS. The findings reported in a 7-part investigative series show “a pattern of increasing use” of…